5 May 2017
A new section "Uremic Toxins" has been established in Toxins
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
I'm delighted to announce that a new section "Uremic Toxins" has been established in Toxins. The section will cover all aspects of uremic toxin research, including but not limited to the identification and characterization of uremic toxins, with studies on their biological effects; generation; complications; removal and kinetics during removal; observational and controlled studies on the biological and clinical impact of concentration changes; and studies on the uremic metabolome, proteome, genome and microbiome.
The Editor-in-Chief for the section will be Professor Raymond Vanholder. Dr. Vanholder is Professor Emeritus at Ghent University and chairman of the European Kidney Health Alliance and the European Chronic Diseases Alliance. He has published more than 700 papers on uremic toxicity and various topics related to clinical nephrology.
I'm confident that Dr. Raymond Vanholder's knowledge and experience will help us expand the journal's scope to uremic toxins, and maintain the high quality of the journal in the future.
The section information and editorial board can be found at https://www.mdpi.com/journal/toxins/sections/uremic_toxins.